Taher, A. Et Al. 2013. THE SAFETY PROFILE OF DEFERASIROX REMAINS CONSISTENT AS NON-TRANSFUSION-DEPENDENT THALASSEMIA PATIENTS APPROACH THE TARGET LIVER IRON CONCENTRATION OF < 3 MG FE/G DW FOR INTERRUPTING CHELATION. HAEMATOLOGICA , vol.98 , 165-166.

Taher, A., Porter, J., Viprakasit, V., Kattamis, A., Chuncharunee, S., Sutcharitchan, P., ... Siritanaratkul, N.(2013). THE SAFETY PROFILE OF DEFERASIROX REMAINS CONSISTENT AS NON-TRANSFUSION-DEPENDENT THALASSEMIA PATIENTS APPROACH THE TARGET LIVER IRON CONCENTRATION OF < 3 MG FE/G DW FOR INTERRUPTING CHELATION. HAEMATOLOGICA , vol.98, 165-166.

Taher, A. Et Al. "THE SAFETY PROFILE OF DEFERASIROX REMAINS CONSISTENT AS NON-TRANSFUSION-DEPENDENT THALASSEMIA PATIENTS APPROACH THE TARGET LIVER IRON CONCENTRATION OF < 3 MG FE/G DW FOR INTERRUPTING CHELATION," HAEMATOLOGICA , vol.98, 165-166, 2013

Taher, A. Et Al. "THE SAFETY PROFILE OF DEFERASIROX REMAINS CONSISTENT AS NON-TRANSFUSION-DEPENDENT THALASSEMIA PATIENTS APPROACH THE TARGET LIVER IRON CONCENTRATION OF < 3 MG FE/G DW FOR INTERRUPTING CHELATION." HAEMATOLOGICA , vol.98, pp.165-166, 2013

Taher, A. Et Al. (2013) . "THE SAFETY PROFILE OF DEFERASIROX REMAINS CONSISTENT AS NON-TRANSFUSION-DEPENDENT THALASSEMIA PATIENTS APPROACH THE TARGET LIVER IRON CONCENTRATION OF < 3 MG FE/G DW FOR INTERRUPTING CHELATION." HAEMATOLOGICA , vol.98, pp.165-166.

@article{article, author={A. Taher Et Al. }, title={THE SAFETY PROFILE OF DEFERASIROX REMAINS CONSISTENT AS NON-TRANSFUSION-DEPENDENT THALASSEMIA PATIENTS APPROACH THE TARGET LIVER IRON CONCENTRATION OF < 3 MG FE/G DW FOR INTERRUPTING CHELATION}, journal={HAEMATOLOGICA}, year=2013, pages={165-166} }